PetrFrantisekHausnerMD

Professor of Medicine, University of Maryland School of Medicine

Dr. Hausner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
22 S Greene St
Baltimore, MD 21201
Phone+1 410-328-2567

Fax+1 410-328-6896

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1994 - 1997
Charles University in PragueClass of 1972, MD

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

PubMed

32 citations
Outcomes after trimodality therapy for esophageal cancer: the impact of histology on failure patterns.
Matthew Koshy, Bruce D. Greenwald, Petr F. Hausner, Mark J. Krasna, Naomi Horiba
American Journal of Clinical Oncology. 2011-06-01
12 citations
Combination Nivolumab/Ipilimumab Immunotherapy For Melanoma With Subsequent Unexpected Cardiac Arrest: A Case Report and Review of Literature.
Zaid H. Khoury, Petr F Hausner, Cynthia L Idzik-starr, Matthew R.A. Frykenberg, John K Brooks
Journal of Immunotherapy. 2019-10-01
67 citations
Phase 2 study of cryptophycin 52 (LY355703) in patients previously treated with platinum based chemotherapy for advanced non-small cell lung cancer.
Martin J. Edelman, David R. Gandara, Petr F. Hausner, Valerie Israel, Donald Thornton
Lung Cancer. 2003-02-01